Cleared Abbreviated

K241751 - NeuroLF (Basic) (FDA 510(k) Clearance)

Also includes:
NeuroLF (Pro) NeuroLF (Advanced) NeuroLF Seat

Class II Radiology device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K241751 · Positrigo AG · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2024
Decision
27d
Days
Class 2
Risk

K241751 is an FDA 510(k) clearance for the NeuroLF (Basic). Classified as System, Tomography, Computed, Emission (product code KPS), Class II - Special Controls.

Submitted by Positrigo AG (Zurich, CH). The FDA issued a Cleared decision on July 15, 2024 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1200 - the FDA radiology and imaging software oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Positrigo AG devices

Submission Details

510(k) Number K241751 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 18, 2024
Decision Date July 15, 2024
Days to Decision 27 days
Submission Type Abbreviated
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
80d faster than avg
Panel avg: 107d · This submission: 27d
Pathway characteristics
Standards-based clearance path. Third-party reviewed.

Device Classification

Product Code KPS System, Tomography, Computed, Emission
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Third Party Review Group, LLC
Dave Yungvirt

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - KPS System, Tomography, Computed, Emission

All 469
Devices cleared under the same product code (KPS) and FDA review panel - the closest regulatory comparables to K241751.
uMI Panvivo (uMI Panvivo LS)
K260524 · Shanghai United Imaging Healthcare Co., Ltd. · Apr 2026
uMI Panvivo (uMI Panvivo)
K253564 · Shanghai United Imaging Healthcare Co., Ltd. · Feb 2026
VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364)
K254001 · Spectrum Dynamics Medical, Ltd. · Jan 2026
AnyScan 3.0 NM Scanner Family
K253844 · Mediso Medical Imaging Systems, Ltd. · Dec 2025
Cartesion Prime (PCD-1000A/3) V10.21
K251370 · Canon Medical Systems Corporation · Dec 2025
PennPET Explorer Positron Emission Tomograph
K251401 · Trustees of the University of Pennsylvania · Nov 2025